Conversely, HS‐10352 displayed no inhibitory effects on cell lines lacking PIK3CA mutations, like the human breast cancer HDQ‐P1 cell line and the human gastric cancer SNU‐1 and MKN‐74 cell lines. The gene discussed is PIK3CA; the disease is breast cancer.